The fact that this MRK regimen is a viable player in the all oral HCV arena was hinted before (#msg-93015431) and is becoming more clear with the AASLD abs.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.